{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2022,4,2]],"date-time":"2022-04-02T11:38:17Z","timestamp":1648899497330},"reference-count":19,"publisher":"Oxford University Press (OUP)","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Mod Rheumatol"],"published-print":{"date-parts":[[2011,8]]},"DOI":"10.1007\/s10165-011-0419-6","type":"journal-article","created":{"date-parts":[[2011,2,23]],"date-time":"2011-02-23T01:31:03Z","timestamp":1298424663000},"page":"352-358","source":"Crossref","is-referenced-by-count":4,"title":["The efficacy and safety of reinstitution of tocilizumab in patients with relapsed active rheumatoid arthritis after long-term withdrawal of tocilizumab"],"prefix":"10.1093","volume":"21","author":[{"given":"Akira","family":"Sagawa","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2011,2,24]]},"reference":[{"key":"419_CR1","doi-asserted-by":"crossref","first-page":"1408","DOI":"10.1111\/j.1572-0241.2002.05784.x","volume":"97","author":"S Kugathasan","year":"2002","unstructured":"Kugathasan S, Levy MB, Saeian K, Vasilopoulos S, Kim JP, Prajapati D, et al. Infliximab retreatment in adults and children with Crohn\u2019s disease: risk factors for the development of delayed severe systemic reaction. Am J Gastroenterol. 2002;97:1408\u201314.","journal-title":"Am J Gastroenterol"},{"key":"419_CR2","first-page":"1896","volume":"35","author":"H Toki","year":"2008","unstructured":"Toki H, Momohara S, Tsukahara S, Ikari K. Infusion reaction to infliximab in a patient with rheumatoid arthritis after discontinuation over 1\u00a0year and readministration. J Rheumatol. 2008;35:1896\u20137.","journal-title":"J Rheumatol"},{"key":"419_CR3","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1136\/ard.2007.072967","volume":"67","author":"T Takeuchi","year":"2008","unstructured":"Takeuchi T, Tatsuki Y, Nogami Y, Ishiguro N, Tanaka Y, Yamanaka H, et al. Postmarketing surveillance of the safety profile of infliximab in 5000 Japanese patients with rheumatoid arthritis. Ann Rheum Dis. 2008;67:189\u201394.","journal-title":"Ann Rheum Dis"},{"key":"419_CR4","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1007\/s12016-009-8140-3","volume":"38","author":"N Emi Aikawa","year":"2010","unstructured":"Emi Aikawa N, de Carvalho JF, Artur Almeida Silva C, Bonfa E. Immunogenicity of anti-TNF-alpha agents in autoimmune diseases. Clin Rev Allergy Immunol. 2010;38:82\u20139.","journal-title":"Clin Rev Allergy Immunol"},{"key":"419_CR5","doi-asserted-by":"crossref","first-page":"1162","DOI":"10.1136\/ard.2006.068064","volume":"66","author":"N Nishimoto","year":"2007","unstructured":"Nishimoto N, Hashimoto J, Miyasaka N, Yamamoto K, Kawai S, Takeuchi T, et al. Study of active controlled monotherapy used for rheumatoid arthritis, an IL-6 inhibitor (SAMURAI): evidence of clinical and radiographic benefit from an x ray reader-blinded randomised controlled trial of tocilizumab. Ann Rheum Dis. 2007;66:1162\u20137.","journal-title":"Ann Rheum Dis"},{"key":"419_CR6","doi-asserted-by":"crossref","first-page":"955","DOI":"10.1002\/art.10877","volume":"48","author":"M Szkudlarek","year":"2003","unstructured":"Szkudlarek M, Court-Payen M, Jacobsen S, Klarlund M, Thomsen HS, Ostergaard M. Interobserver agreement in ultrasonography of the finger and toe joints in rheumatoid arthritis. Arthritis Rheum. 2003;48:955\u201362.","journal-title":"Arthritis Rheum"},{"key":"419_CR7","first-page":"31","volume":"33","author":"B Haraoui","year":"2006","unstructured":"Haraoui B, Cameron L, Ouellet M, White B. Anti-infliximab antibodies in patients with rheumatoid arthritis who require higher doses of infliximab to achieve or maintain a clinical response. J Rheumatol. 2006;33:31\u20136.","journal-title":"J Rheumatol"},{"key":"419_CR8","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1136\/ard.2003.013052","volume":"63","author":"LB Putte van de","year":"2004","unstructured":"van de Putte LB, Atkins C, Malaise M, Sany J, Russell AS, van Riel PL, et al. Efficacy and safety of adalimumab as monotherapy in patients with rheumatoid arthritis for whom previous disease modifying antirheumatic drug treatment has failed. Ann Rheum Dis. 2004;63:508\u201316.","journal-title":"Ann Rheum Dis"},{"key":"419_CR9","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1136\/ard.2006.057406","volume":"66","author":"CJ Laken van der","year":"2007","unstructured":"van der Laken CJ, Voskuyl AE, Roos JC, Stigter van Walsum M, de Groot ER, Wolbink G, et al. Imaging and serum analysis of immune complex formation of radiolabelled infliximab and anti-infliximab in responders and non-responders to therapy for rheumatoid arthritis. Ann Rheum Dis. 2007;66:253\u20136.","journal-title":"Ann Rheum Dis"},{"key":"419_CR10","doi-asserted-by":"crossref","first-page":"3782","DOI":"10.1002\/art.22214","volume":"54","author":"K Bendtzen","year":"2006","unstructured":"Bendtzen K, Geborek P, Svenson M, Larsson L, Kapetanovic MC, Saxne T. Individualized monitoring of drug bioavailability and immunogenicity in rheumatoid arthritis patients treated with the tumor necrosis factor alpha inhibitor infliximab. Arthritis Rheum. 2006;54:3782\u20139.","journal-title":"Arthritis Rheum"},{"key":"419_CR11","doi-asserted-by":"crossref","first-page":"1828","DOI":"10.1093\/rheumatology\/kem261","volume":"46","author":"M Svenson","year":"2007","unstructured":"Svenson M, Geborek P, Saxne T, Bendtzen K. Monitoring patients treated with anti-TNF-alpha biopharmaceuticals: assessing serum infliximab and anti-infliximab antibodies. Rheumatology (Oxford). 2007;46:1828\u201334.","journal-title":"Rheumatology (Oxford)"},{"key":"419_CR12","doi-asserted-by":"crossref","first-page":"1021","DOI":"10.1007\/s10067-008-0866-4","volume":"27","author":"AE Bijl van der","year":"2008","unstructured":"van der Bijl AE, Breedveld FC, Antoni CE, Kalden JR, Kary S, Burmester GR, et al. An open-label pilot study of the effectiveness of adalimumab in patients with rheumatoid arthritis and previous infliximab treatment: relationship to reasons for failure and anti-infliximab antibody status. Clin Rheumatol. 2008;27:1021\u20138.","journal-title":"Clin Rheumatol"},{"key":"419_CR13","doi-asserted-by":"crossref","first-page":"1697","DOI":"10.1136\/ard.2007.083683","volume":"67","author":"BJ Bemt van den","year":"2008","unstructured":"van den Bemt BJ, den Broeder AA, Snijders GF, Hekster YA, van Riel PL, Benraad B, et al. Sustained effect after lowering high-dose infliximab in patients with rheumatoid arthritis: a prospective dose titration study. Ann Rheum Dis. 2008;67:1697\u2013701.","journal-title":"Ann Rheum Dis"},{"key":"419_CR14","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1007\/s10165-008-0045-0","volume":"18","author":"N Miyasaka","year":"2008","unstructured":"Miyasaka N, CHANGE Study investigators. Clinical investigation in highly disease-affected rheumatoid arthritis patients in Japan with adalimumab applying standard and general evaluation: the CHANGE study. Mod Rheumatol. 2008;18:252\u201362.","journal-title":"Mod Rheumatol"},{"key":"419_CR15","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1136\/ard.2004.024182","volume":"64","author":"C Eriksson","year":"2005","unstructured":"Eriksson C, Engstrand S, Sundqvist KG, Rantapaa-Dahlqvist S. Autoantibody formation in patients with rheumatoid arthritis treated with anti-TNF alpha. Ann Rheum Dis. 2005;64:403\u20137.","journal-title":"Ann Rheum Dis"},{"issue":"Suppl3","key":"419_CR16","first-page":"98","volume":"69","author":"N Nishimoto","year":"2010","unstructured":"Nishimoto N, Japanese MRA Study Group for RA. Drug free remission after cessation of actemra monotherapy (DREAM STUDY). Ann Rheum Dis. 2010;69[Suppl 3]:98.","journal-title":"Ann Rheum Dis"},{"issue":"Suppl3","key":"419_CR17","first-page":"537","volume":"69","author":"N Nishimoto","year":"2010","unstructured":"Nishimoto N, Japanese MRA Study Group for RA. Retreatment efficacy and safety of tocilizumab in patients with rheumatoid arthritis at recurrence (RESTORE STUDY). Ann Rheum Dis. 2010;69[Suppl 3]:537.","journal-title":"Ann Rheum Dis"},{"key":"419_CR18","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1007\/s10165-008-0125-1","volume":"19","author":"N Nishimoto","year":"2009","unstructured":"Nishimoto N, Miyasaka N, Yamamoto K, Kawai S, Takeuchi T, Azuma J, et al. Study of active controlled tocilizumab monotherapy for rheumatoid arthritis patients with an inadequate response to methotrexate (SATORI): significant reduction in disease activity and serum vascular endothelial growth factor by IL-6 receptor inhibition therapy. Mod Rheumatol. 2009;19:12\u20139.","journal-title":"Mod Rheumatol"},{"key":"419_CR19","first-page":"851","volume":"53","author":"K Sato","year":"1993","unstructured":"Sato K, Tsuchiya M, Saldanha J, Koishihara Y, Ohsugi Y, Kishimoto T, et al. Reshaping a human antibody to inhibit the interleukin 6-dependent tumor cell growth. Cancer Res. 1993;53:851\u20136.","journal-title":"Cancer Res"}],"container-title":["Modern Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.springerlink.com\/index\/pdf\/10.1007\/s10165-011-0419-6","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,3,9]],"date-time":"2022-03-09T16:25:29Z","timestamp":1646843129000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10165-011-0419-6"}},"subtitle":["Retreatment of patients with rheumatoid arthritis with novel anti-IL-6 receptor antibody after a long-term interval following SAMURAI: the RONIN study"],"short-title":[],"issued":{"date-parts":[[2011,2,24]]},"references-count":19,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2011,8]]}},"alternative-id":["419"],"URL":"https:\/\/doi.org\/10.1007\/s10165-011-0419-6","relation":{},"ISSN":["1439-7595","1439-7609"],"issn-type":[{"value":"1439-7595","type":"print"},{"value":"1439-7609","type":"electronic"}],"subject":[],"published":{"date-parts":[[2011,2,24]]}}}